22 July 2024
Baker McKenzie successfully advises Olink in merger control proceedings before the German Federal Cartel Office
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jan Kresken Lead | Baker McKenzie | Not stated | merger control | Not stated |
| Dr. Anika Schürmann Lead | Baker McKenzie | Not stated | antitrust | Not stated |
| Dr. Nicolas Kredel Lead | Baker McKenzie | Not stated | antitrust | Not stated |
Stated terms
- Stated value
- EUR 2.80bn (around EUR 2.8 billion)
- What the figure measures
- Total transaction value
- Client
- Olink Holding AB (publ)Sell-side
- Counterparties
- Thermo Fisher Scientific Inc (Buy-side)